首页|中性粒细胞/淋巴细胞比值及全身免疫炎症指数在PGI-DLBCL中的预后价值

中性粒细胞/淋巴细胞比值及全身免疫炎症指数在PGI-DLBCL中的预后价值

扫码查看
目的 探究原发胃肠道弥漫大B细胞淋巴瘤(PGI-DLBCL)患者化疗前外周血中性粒细胞/淋巴细胞比值(NLR)、全身免疫炎症指数(SII)与预后之间的关系.方法 选择2010年1月-2021年2月,在徐州医科大学附属医院就诊的93例PGI-DLBCL患者为研究对象,分析患者临床资料,根据受试者工作特征(ROC)曲线确定NLR、SII截断值并分别分为高、低组.分析总结不同组患者的预后生存情况.Kaplan-Meier法、Log-rank检验进行生存分析,Cox比例风险回归模型进行危险因素分析.结果 根据ROC曲线确定NLR的截断值为3.974,SII的截断值为853.775,根据截断值分为高NLR组31例,低NLR组62例,高SII组40例,低SII组53例.Cox回归模型单因素分析显示,ANC>4.620、MLR>0.254、NLR>3.974、SII>853.775均为影响患者5年PFS的危险因素(P均<0.05),多因素分析提示,NLR>3.974、SII>853.775是影响患者预后的独立危险因素(P均<0.05).组间临床特征分析提示,高NLR组、高SII组倾向于分布在临床分期晚(x2=7.971、6.996,P=0.004、0.008),国际预后指数(IPI)评分高(x2=13.527、8.877,P<0.001、0.003)的患者.生存分析提示,低NLR组的中位无进展生存(PFS)、中位总体生存(OS)时间比高NLR组患者的长,低SII组的中位PFS、中位OS时间比高SII组患者的长,差异均有统计学意义(P均<0.05).结论 初诊时NLR、SII是PGI-DLBCL患者的独立预后危险因素,NLR、SII越高,其预后越差.
The prognostic value of neutrophil/lymphocyte ratio and systemic immunoinflammatory index in PGI-DLBCL
Objective To investigate the relationship between peripheral neutrophil/lymphocyte ratio(NLR),systemic immunoinflammatory index(SII)and prognosis in patients with primary gastrointestinal diffuse large B-cell lymphoma(PGI-DLBCL)before chemotherapy.Methods A total of 93 PGI-DLBCL patients attending the Affiliated Hospital of Xuzhou Medical University from January 2010 to February 2021 were selected as the study subjects.Clinical data of patients diagnosed with PGI-DLBCL were reviewed and analyzed.The truncation values of NLR and SII were determined according to receiver operating characteristic(ROC),and then divided into high and low group,respectively.The prognosis and survival of the two groups were analyzed and summarized.Survival analysis was performed by Kaplan-Meier test and Log-rank test,and risk factors were analyzed by Cox proportional hazard regression model.Results According to ROC curve,the cut-off value of NLR was 3.974 and that of SII was 853.775.According to the cut-off value,31 patients were classified in the high NLR group,62 in the low NLR group,40 in the high SII group and 53 in the low SII group.Univariate analysis of Cox regression model showed that ANC>4.620,MLR>0.254,NLR>3.974 and SII>853.775 were all risk factors affecting 5-year PFS of patients(all P<0.05).Multivariate analysis indicated that NLR>3.974 and SII>853.775 were independent risk factors affecting the prognosis of patients(all P<0.05).Analysis of clinical features between groups suggested that the high NLR group and the high SII group tended to be distributed in patients with late clinical stage(c2=7.971,6.996,P=0.004,0.008)and high international prognostic(IPI)score(c2=13.527,8.877,P<0.001,0.003).Survival analysis indicated that patients in the low NLR group had longer median progress free survival(PFS)and median overall survival(OS)than those in the high NLR group,and patients in the low SII group had longer median PFS and median OS than those in the high SII group,all the differences were statistically significant(all P<0.05).Conclusions NLR and SII were independent prognostic risk factors for PGI-DLBCL patients at initial diagnosis.The higher the NLR and SII,the worse was the prognosis.

Neutrophil/lymphocyte ratioSystemic immune-inflammatory indexPGI-DLBCL

董舒蕾、朱锋

展开 >

徐州医科大学研究生院,江苏 徐州 221004

徐州医科大学附属医院血液内科,江苏 徐州 221002

中性粒细胞/淋巴细胞比值 全身免疫炎症指数 原发胃肠道弥漫大B细胞淋巴瘤

国家自然科学基金面上项目江苏省"六个一工程"拔尖人才科研六大高峰人才项目

82170187LGY2018084

2024

热带医学杂志
广东省寄生虫学会 中华预防医学会

热带医学杂志

CSTPCD
影响因子:0.643
ISSN:1672-3619
年,卷(期):2024.24(5)
  • 1